⌘K

Login Start Free

Home/Filings/4/0001415889-25-014467

4//SEC Filing

Andrade Robert 4

Accession 0001415889-25-014467

CIK 0001211583other

View on SEC.gov Company Profile

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:20 PM ET

Size

7.3 KB

Accession

0001415889-25-014467

Insider Transaction Report

Form 4

Period: 2025-05-22

FENNEC PHARMACEUTICALS INC.FENC

CHIEF FINANCIAL OFFICER

Transactions

Exercise/Conversion
Common shares
2025-05-22$5.10/sh+8,220$41,922→ 158,520 total
Exercise/Conversion
Stock Options
2025-05-22$5.10/sh−8,220$41,922→ 850,751 total
Exercise: $5.10From: 2017-06-27Exp: 2027-06-27→ Options (8,220 underlying)

Footnotes (1)

[F1]Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.

Documents

1 file

4
form4-05232025_040501.xmlPrimary

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1

filerCIK 0001468308

Filing Metadata

Form type: 4
Filed: May 22, 8:00 PM ET
Accepted: May 23, 4:20 PM ET
Size: 7.3 KB

View on SEC.gov